Onyx Pharmaceuticals

Summary

Onyx Pharmaceuticals is a business^[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (97 views/month).^[2]

Key Facts

• Onyx Pharmaceuticals is in the country of United States^[3].
• Onyx Pharmaceuticals is in the country of US^[4].
• Onyx Pharmaceuticals's instance of is recorded as business^[5].
• Onyx Pharmaceuticals's instance of is recorded as public company^[6].
• Onyx Pharmaceuticals's founder is recorded as Frank McCormick^[7].
• Onyx Pharmaceuticals's headquarters location is recorded as South San Francisco^[8].
• Onyx Pharmaceuticals's stock exchange is recorded as Nasdaq^[9].
• Onyx Pharmaceuticals's industry is recorded as biotechnology^[10].
• February 1992 marks the founding of Onyx Pharmaceuticals^[11].
• Onyx Pharmaceuticals was dissolved in August 25, 2013^[12].
• Onyx Pharmaceuticals's official website is recorded as http://www.onyx.com/^[13].
• Onyx Pharmaceuticals's product or material produced is recorded as sorafenib^[14].
• Onyx Pharmaceuticals's official name is recorded as {'lang': 'en-us', 'text': 'Onyx Pharmaceuticals, Inc.'}^[15].
• Onyx Pharmaceuticals's legal form is recorded as Delaware corporation^[16].
• Onyx Pharmaceuticals's legal form is recorded as XTIQ^[17].
• Onyx Pharmaceuticals's merged into is recorded as Amgen^[18].

Product Details

The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.

GLEIF Golden Copy — Level 1 entity data

• Legal Entity Identifier (LEI): 549300K47GO90N8J4853^[19]

• Registered legal name: Onyx Pharmaceuticals, Inc.^[20]

• Legal jurisdiction: US-DE^[21]

• GLEIF entity category: GENERAL^[22]

• Legal form (ISO 20275 ELF): XTIQ^[23]

• Entity status: ACTIVE^[24]

• LEI registration status: LAPSED^[25]

• LEI first registered: 2013-04-05^[26]

• LEI last updated: 2023-08-04^[27]

• LEI next renewal: 2014-04-05^[28]

• Managing LOU: 5493001KJTIIGC8Y1R12^[29]

• Registration authority: RA999999^[30]

• Conformity flag: NON_CONFORMING^[31]

Body

Founding

Onyx Pharmaceuticals's founder is recorded as Frank McCormick^[7]. February 1992 marks the founding of it^[11].

Identity

Onyx Pharmaceuticals's official name is recorded as {'lang': 'en-us', 'text': 'it, Inc.'}^[15].

Operations

Onyx Pharmaceuticals's headquarters location is recorded as South San Francisco^[8].

Industry

Onyx Pharmaceuticals's industry is recorded as biotechnology^[10].

Ownership

Onyx Pharmaceuticals's stock exchange is recorded as Nasdaq^[9]. Its product or material produced is recorded as sorafenib^[14].

Dissolution

Onyx Pharmaceuticals was dissolved in August 25, 2013^[12].

Why It Matters

Onyx Pharmaceuticals ranks in the top 4% of business entities by monthly Wikipedia readership (97 views/month).^[2]